212 related articles for article (PubMed ID: 33635151)
21. The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study.
Barć K; Gospodarczyk-Szot K; Nojszewska M; Podlecka-Piętowska A; Zakrzewska-Pniewska B
Mult Scler Relat Disord; 2020 Sep; 44():102265. PubMed ID: 32575026
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
23. Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.
Iorio R; Damato V; Mirabella M; Evoli A; Marti A; Plantone D; Frisullo G; Batocchi AP
J Neurol; 2013 Sep; 260(9):2396-402. PubMed ID: 23793787
[TBL] [Abstract][Full Text] [Related]
24. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.
Sepúlveda M; Sola-Valls N; Escudero D; Rojc B; Barón M; Hernández-Echebarría L; Gómez B; Dalmau J; Saiz A; Graus F
Mult Scler; 2018 Nov; 24(13):1753-1759. PubMed ID: 28920766
[TBL] [Abstract][Full Text] [Related]
25. Overlap syndrome of anti-aquaporin-4 positive neuromyelitis optica spectrum disorder and systemic lupus erythematosus: A systematic review of individual patient data.
Kopp CR; Prasad CB; Naidu S; Sharma V; Misra DP; Agarwal V; Sharma A
Lupus; 2023 Sep; 32(10):1164-1172. PubMed ID: 37487596
[TBL] [Abstract][Full Text] [Related]
26. [Actual issues of serum aquaporin-4 autoantibodies evaluation in the diagnostics of neuromyelitis optica spectrum disorders].
Krasnov VS; Totolyan NA; Nazarov VD; Mazing AV; Makshakov GS; Lapin SV; Evdoshenko EP; Skoromets AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):24-31. PubMed ID: 32844626
[TBL] [Abstract][Full Text] [Related]
27. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
28. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
29. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
30. Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases.
Zhang J; Liu F; Wang Y; Yang Y; Huang Y; Zhao H; Bi Y; Shi T; Guo S; Wang M
Mult Scler; 2017 Dec; 23(14):1950-1954. PubMed ID: 28580873
[TBL] [Abstract][Full Text] [Related]
31. Longitudinally Extensive Transverse Myelitis: A Retrospective Study Differentiating Neuromyelitis Optica Spectrum Disorder From Other Etiologies.
Paudel S; Nepal G; Guragain S; Shah S; Paudel BS; Ojha R; Rajbhandari R; Karn R; Gajurel BP; Paudel S
Cureus; 2021 Mar; 13(3):e13968. PubMed ID: 33884229
[TBL] [Abstract][Full Text] [Related]
32. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel T; Giglhuber K; Aktas O; Ayzenberg I; Bellmann-Strobl J; Häußler V; Havla J; Hellwig K; Hümmert MW; Jarius S; Kleiter I; Klotz L; Krumbholz M; Paul F; Ringelstein M; Ruprecht K; Senel M; Stellmann JP; Bergh FT; Trebst C; Tumani H; Warnke C; Wildemann B; Berthele A;
J Neurol; 2024 Jan; 271(1):141-176. PubMed ID: 37676297
[TBL] [Abstract][Full Text] [Related]
33. Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD.
Hyun JW; Lee HL; Park J; Kim J; Min JH; Kim BJ; Kim SW; Shin HY; Huh SY; Kim W; Seo JW; Kim KH; Kim SH; Kim HJ
Mult Scler; 2022 May; 28(6):989-992. PubMed ID: 34865555
[TBL] [Abstract][Full Text] [Related]
34. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
[TBL] [Abstract][Full Text] [Related]
35. Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis.
Juryńczyk M; Klimiec-Moskal E; Kong Y; Hurley S; Messina S; Yeo T; Jenkinson M; Leite MI; Palace J
J Neurol; 2022 Jan; 269(1):269-279. PubMed ID: 34043042
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
Yang CS; Zhang DQ; Wang JH; Jin WN; Li MS; Liu J; Zhang CJ; Li T; Shi FD; Yang L
CNS Neurosci Ther; 2014 Jan; 20(1):32-9. PubMed ID: 23890015
[TBL] [Abstract][Full Text] [Related]
37. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
Park JS; Hwang SJ; Shin JH; Kim DS
J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
[TBL] [Abstract][Full Text] [Related]
39. A score that predicts aquaporin-4 IgG positivity in patients with longitudinally extensive transverse myelitis.
Campetella L; Papi C; Spagni G; Sabatelli E; Mariotto S; Gastaldi M; Masi G; Carta S; Ahmad L; Rossi F; Maniscalco GT; De Luca G; Iorio R
Eur J Neurol; 2023 Aug; 30(8):2534-2538. PubMed ID: 37170839
[TBL] [Abstract][Full Text] [Related]
40. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders.
Hu H; You X; Ye J
Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
